APA (7th ed.) Citation

G, D., J, S., E, M., G, D., A, L., C, F., . . . G, M. (2020). Reduced Rivaroxaban Dose Versus Dual Antiplatelet Therapy After Left Atrial Appendage Closure: ADRIFT a Randomized Pilot Study. Circulation. Cardiovascular interventions, 13(7), e008481. https://doi.org/10.1161/CIRCINTERVENTIONS.119.008481

Chicago Style (17th ed.) Citation

G, Duthoit, et al. "Reduced Rivaroxaban Dose Versus Dual Antiplatelet Therapy After Left Atrial Appendage Closure: ADRIFT a Randomized Pilot Study." Circulation. Cardiovascular Interventions 13, no. 7 (2020): e008481. https://doi.org/10.1161/CIRCINTERVENTIONS.119.008481.

MLA (9th ed.) Citation

G, Duthoit, et al. "Reduced Rivaroxaban Dose Versus Dual Antiplatelet Therapy After Left Atrial Appendage Closure: ADRIFT a Randomized Pilot Study." Circulation. Cardiovascular Interventions, vol. 13, no. 7, 2020, p. e008481, https://doi.org/10.1161/CIRCINTERVENTIONS.119.008481.